Logo image of XAIR

BEYOND AIR INC (XAIR) Stock Fundamental Analysis

NASDAQ:XAIR - Nasdaq - US08862L1035 - Common Stock - Currency: USD

0.39  +0.03 (+8.33%)

Premarket: 0.385 -0.01 (-1.28%)

Fundamental Rating

2

Overall XAIR gets a fundamental rating of 2 out of 10. We evaluated XAIR against 191 industry peers in the Health Care Equipment & Supplies industry. XAIR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XAIR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XAIR had negative earnings in the past year.
In the past year XAIR has reported a negative cash flow from operations.
XAIR had negative earnings in each of the past 5 years.
In the past 5 years XAIR always reported negative operating cash flow.
XAIR Yearly Net Income VS EBIT VS OCF VS FCFXAIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -104.67%, XAIR is doing worse than 83.68% of the companies in the same industry.
With a Return On Equity value of -197.27%, XAIR is not doing good in the industry: 75.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -104.67%
ROE -197.27%
ROIC N/A
ROA(3y)-76.83%
ROA(5y)-72.3%
ROE(3y)-149.03%
ROE(5y)-127.06%
ROIC(3y)N/A
ROIC(5y)N/A
XAIR Yearly ROA, ROE, ROICXAIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

XAIR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XAIR Yearly Profit, Operating, Gross MarginsXAIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

4

2. Health

2.1 Basic Checks

XAIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XAIR has been increased compared to 1 year ago.
The number of shares outstanding for XAIR has been increased compared to 5 years ago.
The debt/assets ratio for XAIR is higher compared to a year ago.
XAIR Yearly Shares OutstandingXAIR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XAIR Yearly Total Debt VS Total AssetsXAIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

XAIR has an Altman-Z score of -9.06. This is a bad value and indicates that XAIR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XAIR (-9.06) is worse than 78.42% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that XAIR is not too dependend on debt financing.
XAIR has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: XAIR outperforms 44.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z -9.06
ROIC/WACCN/A
WACC11.29%
XAIR Yearly LT Debt VS Equity VS FCFXAIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

XAIR has a Current Ratio of 5.76. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
XAIR has a Current ratio of 5.76. This is amongst the best in the industry. XAIR outperforms 81.58% of its industry peers.
A Quick Ratio of 5.38 indicates that XAIR has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.38, XAIR belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.76
Quick Ratio 5.38
XAIR Yearly Current Assets VS Current LiabilitesXAIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

XAIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.55%, which is quite impressive.
XAIR shows a strong growth in Revenue. In the last year, the Revenue has grown by 680.67%.
Measured over the past years, XAIR shows a very negative growth in Revenue. The Revenue has been decreasing by -31.56% on average per year.
EPS 1Y (TTM)31.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.1%
Revenue 1Y (TTM)680.67%
Revenue growth 3Y10.03%
Revenue growth 5Y-31.56%
Sales Q2Q%233.89%

3.2 Future

The Earnings Per Share is expected to grow by 20.75% on average over the next years. This is a very strong growth
XAIR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 208.93% yearly.
EPS Next Y56.62%
EPS Next 2Y30.41%
EPS Next 3Y20.75%
EPS Next 5YN/A
Revenue Next Year161.35%
Revenue Next 2Y209.09%
Revenue Next 3Y208.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XAIR Yearly Revenue VS EstimatesXAIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
XAIR Yearly EPS VS EstimatesXAIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

XAIR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XAIR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XAIR Price Earnings VS Forward Price EarningsXAIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XAIR Per share dataXAIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as XAIR's earnings are expected to grow with 20.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.41%
EPS Next 3Y20.75%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XAIR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND AIR INC

NASDAQ:XAIR (2/4/2025, 8:16:38 PM)

Premarket: 0.385 -0.01 (-1.28%)

0.39

+0.03 (+8.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)02-10 2025-02-10/amc
Inst Owners34.4%
Inst Owner Change1.55%
Ins Owners22.24%
Ins Owner Change23.82%
Market Cap28.15M
Analysts81.82
Price Target2.55 (553.85%)
Short Float %1.67%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.98%
Min EPS beat(2)3.34%
Max EPS beat(2)16.63%
EPS beat(4)4
Avg EPS beat(4)13.33%
Min EPS beat(4)3.34%
Max EPS beat(4)25.85%
EPS beat(8)5
Avg EPS beat(8)1.24%
EPS beat(12)6
Avg EPS beat(12)-12.67%
EPS beat(16)7
Avg EPS beat(16)-12.56%
Revenue beat(2)0
Avg Revenue beat(2)-20.52%
Min Revenue beat(2)-24.93%
Max Revenue beat(2)-16.12%
Revenue beat(4)0
Avg Revenue beat(4)-23.33%
Min Revenue beat(4)-38.33%
Max Revenue beat(4)-13.95%
Revenue beat(8)0
Avg Revenue beat(8)-53.45%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)60.26%
EPS NY rev (1m)0%
EPS NY rev (3m)23.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-75.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-55.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.02
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS0.03
BVpS0.39
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -104.67%
ROE -197.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-76.83%
ROA(5y)-72.3%
ROE(3y)-149.03%
ROE(5y)-127.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 256.79%
Cap/Sales 303.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.76
Quick Ratio 5.38
Altman-Z -9.06
F-Score6
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)382.11%
Cap/Depr(5y)319.03%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.1%
EPS Next Y56.62%
EPS Next 2Y30.41%
EPS Next 3Y20.75%
EPS Next 5YN/A
Revenue 1Y (TTM)680.67%
Revenue growth 3Y10.03%
Revenue growth 5Y-31.56%
Sales Q2Q%233.89%
Revenue Next Year161.35%
Revenue Next 2Y209.09%
Revenue Next 3Y208.93%
Revenue Next 5YN/A
EBIT growth 1Y8.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.61%
EBIT Next 3Y47.01%
EBIT Next 5YN/A
FCF growth 1Y-71.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.71%
OCF growth 3YN/A
OCF growth 5YN/A